Unknown

Dataset Information

0

Airway Basal Stem Cells in COVID-19 Exhibit a Proinflammatory Signature and Impaired Mucocililary Differentiation.


ABSTRACT: Airway basal stem cells (BSCs) play a critical role in epithelial regeneration. Whether coronavirus disease (COVID-19) affects BSC function is unknown. Here, we derived BSC lines from patients with COVID-19 using tracheal aspirates (TAs) to circumvent the biosafety concerns of live-cell derivation. We show that BSCs derived from the TAs of control patients are bona fide bronchial BSCs. TA BSCs from patients with COVID-19 tested negative for severe acute respiratory syndrome coronavirus 2 RNA; however, these so-termed COVID-19-exposed BSCs in vitro resemble a predominant BSC subpopulation uniquely present in patients with COVID-19, manifested by a proinflammatory gene signature and STAT3 hyperactivation. Furthermore, the sustained STAT3 hyperactivation drives goblet cell differentiation of COVID-19-exposed BSCs in an air-liquid interface. Last, these phenotypes of COVID-19-exposed BSCs can be induced in control BSCs by cytokine cocktail pretreatment. Taken together, acute inflammation in COVID-19 exerts a long-term impact on mucociliary differentiation of BSCs.

SUBMITTER: Bankoti K 

PROVIDER: S-EPMC10768838 | biostudies-literature | 2024 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

Airway Basal Stem Cells in COVID-19 Exhibit a Proinflammatory Signature and Impaired Mucocililary Differentiation.

Bankoti Kamakshi K   Wang Wei W   Amonkar Gaurang M GM   Xiong Linjie L   Shui Jessica E JE   Zhao Caiqi C   Van Eric E   Mwase Chimwemwe C   Park Jin-Ah JA   Mou Hongmei H   Fang Yinshan Y   Que Jianwen J   Bai Yan Y   Lerou Paul H PH   Ai Xingbin X  

American journal of respiratory cell and molecular biology 20240101 1


Airway basal stem cells (BSCs) play a critical role in epithelial regeneration. Whether coronavirus disease (COVID-19) affects BSC function is unknown. Here, we derived BSC lines from patients with COVID-19 using tracheal aspirates (TAs) to circumvent the biosafety concerns of live-cell derivation. We show that BSCs derived from the TAs of control patients are <i>bona fide</i> bronchial BSCs. TA BSCs from patients with COVID-19 tested negative for severe acute respiratory syndrome coronavirus 2  ...[more]

Similar Datasets

2023-06-01 | GSE212412 | GEO
| S-EPMC8864005 | biostudies-literature
2023-06-01 | GSE212411 | GEO
2023-06-01 | GSE212410 | GEO
| S-EPMC3778678 | biostudies-literature
| S-EPMC8322461 | biostudies-literature
| S-EPMC5090214 | biostudies-literature
| PRJNA875391 | ENA
| S-EPMC6708250 | biostudies-literature
| S-ECPF-GEOD-19722 | biostudies-other